Form 8-K - Current report:
SEC Accession No. 0001558370-25-003502
Filing Date
2025-03-24
Accepted
2025-03-24 08:15:12
Documents
21
Period of Report
2025-03-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20250320x8k.htm   iXBRL 8-K 46923
2 EX-10.1 hrmy-20250320xex10d1.htm EX-10.1 105093
3 EX-99.1 hrmy-20250320xex99d1.htm EX-99.1 31320
4 GRAPHIC hrmy-20250320xex10d1004.jpg GRAPHIC 643
5 GRAPHIC hrmy-20250320xex10d1005.jpg GRAPHIC 875
6 GRAPHIC hrmy-20250320xex10d1006.jpg GRAPHIC 899
7 GRAPHIC hrmy-20250320xex10d1007.jpg GRAPHIC 803
8 GRAPHIC hrmy-20250320xex10d1008.jpg GRAPHIC 679
9 GRAPHIC hrmy-20250320xex99d1001.jpg GRAPHIC 10901
  Complete submission text file 0001558370-25-003502.txt   357424

Data Files

Seq Description Document Type Size
10 EX-101.SCH hrmy-20250320.xsd EX-101.SCH 3299
11 EX-101.LAB hrmy-20250320_lab.xml EX-101.LAB 15929
12 EX-101.PRE hrmy-20250320_pre.xml EX-101.PRE 10082
23 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20250320x8k_htm.xml XML 4879
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 25762312
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)